AngioSoma

20 articles about AngioSoma

• AngioSoma, Inc., Soon To Be GlobeStar Therapeutics Corporation, Retains Sichenzia Ross Ference, LLP As Outside Securities Counsel

  6/9/2021

  Law Firm Selected Because of Their Commitment to Excellence and Securities Expertise.

• AngioSoma, Inc. Is Pleased To Welcome Robert Chicoski, CPA As Our New Chief Financial Officer and Treasurer

  5/12/2021

  AngioSoma, Inc. (OTC PINK:SOAN) has added Robert Chicoski as its Chief Financial Officer and Treasurer. Chicoski has decades of corporate financial, tax, audit and forensic accounting experience to the AngioSoma team. Headquartered in Richland, Washington, AngioSoma, Inc. is a fast-growing company focused on providing medical research, development and treatment

• AngioSoma, Inc. Is Pleased To Welcome Darryl Morris As A Strategic Economic Advisor

  5/11/2021

  AngioSoma, Inc. (OTC PINK:SOAN) has added Darryl Morris as a Strategic Economic Advisor. Morris has over three decades of economic, strategic, and market intelligence experience working with companies, such as Abbott Laboratories.

• AngioSoma, Inc. Is Pleased To Welcome Dr. Leonard Wisneski, MD, FACP As The Medical Advisory Board Chairman

  5/4/2021

  AngioSoma, Inc. has added Dr. Leonard Wisneski, MD, FACP as the Chair of the Medical Advisory Board.

• AngioSoma, Inc. Is Pleased To Welcome Steven F. Penderghast To Its Board Of Directors

  4/21/2021

  AngioSoma, Inc. has added Steven F. Penderghast to its Board of Directors. Penderghast has experience working in medical sciences, as well as his leadership roles at major health care organizations, including Baxter Healthcare and CR Bard Inc., will bring additional resources and expertise to the AngioSoma team.

• AngioSoma, Inc. Adds David Croom As Executive Vice President

  4/20/2021

  AngioSoma, Inc. has hired David Croom as an Executive Vice President. Mr. Croom brings decades of experience in finance, sales, and operations to the AngioSoma team.

• AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer.

  4/19/2021

  Greenwald's experience in public relations and marketing will play a key role in the growth of AngioSoma

• eQuine Holdings Discloses 8% Stake In AngioSoma (SOAN)

  12/28/2018

  eQuine Holdings, a Class II Multi-Family Office, has disclosed an eight percent (8%) equity stake in AngioSoma (OTC-PINK:SOAN).

• AngioSoma Announces New Ecommerce Platform Featuring Innovative Products

  9/24/2018

  AngioSoma (OTC: SOAN) announced today the launch of their new ecommerce site for its retail brand, SomaCeuticals™.

• AngioSoma to Organize Business to Enhance Future Success

  9/17/2018

  New Business Units Created to Focus Resources on Growth Opportunities

• AngioSoma, Inc. Announces Selection of Regulatory Firm for Flagship Drug

  6/18/2018

  AngioSoma, Inc. is excited to announce that we have identified a regulatory firm who can assist taking our patented flagship drug, Liprostin™, through the FDA approval process. 

• AngioSoma, Inc. (OTC: SOAN) Announces Launch of www.soma-ceuticals.com Website

  4/2/2018

  We are pleased to announce we have initiated our new website, http://www.soma-ceuticals.com to market our SomaceuticalsTM line of health supplements.

• AngioSoma Announces Completion of Products for Market

  2/5/2018

  We are pleased to announce we are launching a line of supplements under our SomaceuticalsTM common identity to be marketed on our upcoming website to be named soma-ceuticals.com.

• AngioSoma Appoints New CEO

  12/9/2016

• AngioSoma Appoints New CEO

  12/8/2016

• AngioSoma To Upgrade Its Omnicath Patents Into Omnicath 2 Atherectomy Catheter

  11/4/2016

• Dr. Jackie R. See M.D. Joins AngioSoma's Scientific Advisory Board

  10/21/2016

• AngioSoma Files 3 New Patent Applications on Liprostin

  10/11/2016

• AngioSoma Announces A Liprostin Focused Joint Venture

  10/5/2016

• AngioSoma Welcomes Dr. Tom Garcia To Scientific Advisory Board

  7/29/2016